Cover Image

Evaluating the optimal duration of medication treatment for opioid use disorder

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Corey J. Hayes, Rebecca A. Raciborski, Mahip Acharya, Nahiyan Bin Noor, Edward V. Nunes, T. John Winhusen
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	Addiction
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Medications for opioid use disorder: Predictors of early discontinuation and reduction of overdose risk in US military veterans by medication type
by: Corey J. Hayes, et al.
Published: (2024)

Impact of study design decisions on identification of treatment initiators of medications for opioid use disorder
by: Payel J. Roy, et al.
Published: (2025)

Patient outcomes following buprenorphine treatment for opioid use disorder: A retrospective analysis of the influence of patient‐ and prescriber‐level characteristics in Massachusetts, USA
by: Gary J. Young, et al.
Published: (2024)

Empirically contrasting urine drug screening‐based opioid use disorder treatment outcome definitions
by: Laura Brandt, et al.
Published: (2024)

Case Series: Magnitude and duration of fentanyl and xylazine detection in the urine of persons with opioid use disorder
by: Helen E. Bird, et al.
Published: (2025)

Pharmacological treatment strategies to manage precipitated withdrawal following the administration of buprenorphine in opioid use disorder: A systematic review
by: Emmert Roberts, et al.
Published: (2026)

Commentary on Schmidt et al.: Informed patient preference and prioritizing access to medications for opioid use disorder for pregnant individuals
by: Jake R. Morgan, et al.
Published: (2024)

A comparative study of treatment retention in opioid use disorder: Subcutaneous injectable versus sublingual buprenorphine
by: Charles Deng, et al.
Published: (2025)

Potential health impacts of comprehensive access to opioid use disorder treatment in United States correctional facilities: A synthetic analysis
by: Jake J. Smith, et al.
Published: (2025)

Exploring clinical profile and treatment outcome differences based on baseline smoking and alcohol co‐use status among individuals initiating medication for opioid use disorder treatment
by: Gabriela León, et al.
Published: (2025)

Commentary on D'Agata Mount et al.: Higher dose buprenorphine to improve retention in opioid use disorder treatment, prevent relapse, and optimize integrated care interventions
by: Paolo Mannelli
Published: (2024)

Systematic review of patient‐reported outcome measures for opioid use disorder recovery
by: Jarratt D. Pytell, et al.
Published: (2025)

Evaluating comparative effect of non‐pharmacological interventions adjunctive to opioid agonist therapy for opioid use disorder: A systematic review with network meta‐analysis
by: Bei Lv, et al.
Published: (2026)

An exploratory analysis of 5‐alpha reductase inhibitors and risk of opioid use disorder among male Medicare beneficiaries receiving prescription opioid medications
by: Abdelrahman G. Tawfik, et al.
Published: (2025)

Trajectories of medication for opioid use disorder and their impact on HIV testing among people who inject drugs in India: A longitudinal assessment of clinic‐based data
by: Allison M. McFall, et al.
Published: (2024)

Navigating new norms: Addiction specialists' perspectives on opioid use disorder treatments and policy challenges in the fentanyl era
by: Jeremy Weleff, et al.
Published: (2024)

Questioning methadone split‐dosing for analgesia among hospitalized patients with opioid use disorder
by: Dale Terasaki, et al.
Published: (2024)

Academic detailing is effective at altering clinician practice and patient outcomes for opioid use disorder
by: Jonathan Zhang, et al.
Published: (2026)

Navigating pregnancy and addiction recovery: Patient perspectives on perinatal care interventions for women with opioid use disorder in Kentucky, USA
by: Hilary L. Surratt, et al.
Published: (2026)

A pilot study of virtual reality for inpatients with opioid use disorder
by: Herbert J. Greenwald, et al.
Published: (2024)

The dopamine 3 receptor as a candidate biomarker and therapeutic for opioid use disorder
by: Matthew L. Banks, et al.
Published: (2024)

Predictors of emergency medical transport refusal following opioid overdose in Washington, DC
by: Ben Turley, et al.
Published: (2024)

Development and evaluation of a machine learning model to predict acute care for opioid use disorder among Medicaid enrollees engaged in a community‐based treatment program
by: Lingshu Xue, et al.
Published: (2025)

State inequities: Gaps in planned treatment for criminal legal referrals with opioid use disorder across two decades of US treatment admissions
by: Nicholas L. Bormann, et al.
Published: (2024)

Retention in opioid agonist treatment during pregnancy and variations according to treatment and maternal characteristics
by: Bianca Varney, et al.
Published: (2026)

Associations among social determinants of health and opioid use disorder and overdose: An umbrella review
by: Lauren B. Loeffel, et al.
Published: (2026)

The impact of opioid, cannabis and cocaine use disorder on the risk of diabetic retinopathy in patients with type 2 diabetes mellitus
by: Ming‐Pei Yueh, et al.
Published: (2025)

Dose‐specific clinical outcomes in patients with opioid use disorder treated with 24–32 mg/day of buprenorphine
by: Julia D’Agata Mount, et al.
Published: (2024)

Comparative effectiveness of alternative times to opioid agonist treatment taper initiation on taper completion and all‐cause mortality among people with opioid use disorder: A retrospective population‐based target trial emulation study in British Columbia, Canada, 2010–2020
by: Ruyu Yan, et al.
Published: (2026)

Increased cancer incidence and mortality among people with opioid use‐related disorders: A nation‐wide cohort study
by: Emil Kostovski, et al.
Published: (2024)

Analysis of nonfatal suicide attempts and demographic characteristics of US military veterans with opioid use disorder: A descriptive VA medical center study
by: Muhammet Celik, et al.
Published: (2024)

Associations of emotional experience with gaming duration and risk of gaming disorder among adolescent gamers: An ecological momentary assessment study
by: Camilla K. M. Lo, et al.
Published: (2025)

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review
by: Theodore Piper, et al.
Published: (2025)

Addressing tobacco use in the context of opioid use disorder: A systematic review of smoking cessation interventions
by: Suprit Parida, et al.
Published: (2026)

Call for papers on psychedelic‐assisted treatment for substance use disorders
Published: (2024)

Primary care's most pressing needs to address opioid use disorder: A qualitative study
by: Elise A. Robertson, et al.
Published: (2026)

Relative risks of adverse effects across different opioid agonist treatments—A systematic review and meta‐analysis
by: Maximilian Meyer, et al.
Published: (2025)

A descriptive analysis of rural‐urban overdose experiences among incarcerated women with opioid use disorder
by: Megan F. Dickson, et al.
Published: (2025)

Updated OUD PIP: Take this free, updated PIP activity on treating opioid use disorder
Published: (2025)

Comment on Domzaridou et al .: Recognising the complexities of co‐prescriptions and lifestyle factors in opioid agonist treatment
by: Adam Bakker, et al.
Published: (2024)